131 related articles for article (PubMed ID: 2910546)
21. Value of preexisting bundle branch block in the electrocardiographic differentiation of supraventricular from ventricular origin of wide QRS tachycardia.
Dongas J; Lehmann MH; Mahmud R; Denker S; Soni J; Akhtar M
Am J Cardiol; 1985 Mar; 55(6):717-21. PubMed ID: 3976515
[TBL] [Abstract][Full Text] [Related]
22. Cycle length-dependent effects on normal and abnormal intraventricular electrograms: effect of procainamide.
Schmitt C; Kadish AH; Balke WC; Turk K; Buxton AE; Josephson ME; Marchlinski FE
J Am Coll Cardiol; 1988 Aug; 12(2):395-403. PubMed ID: 3392333
[TBL] [Abstract][Full Text] [Related]
23. Termination of ventricular tachycardia: role of tachycardia cycle length.
Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME
Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
25. Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.
Aizawa Y; Chinushi M; Kitazawa H; Washizuka T; Abe A; Shibata A; Kodama I
Heart; 1996 Mar; 75(3):281-6. PubMed ID: 8800993
[TBL] [Abstract][Full Text] [Related]
26. Incidence and mechanism of interruption of reentrant ventricular tachycardia with rapid ventricular pacing.
Aizawa Y; Niwano S; Chinushi M; Tamura M; Kusano Y; Miyajima T; Kitazawa H; Shibata A
Circulation; 1992 Feb; 85(2):589-95. PubMed ID: 1735154
[TBL] [Abstract][Full Text] [Related]
27. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Naitoh N; Washizuka T; Takahashi K; Aizawa Y
Jpn Circ J; 1998 Apr; 62(4):267-73. PubMed ID: 9583460
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of intravenous procainamide during ventricular tachycardia.
Sharma AD; Purves P; Yee R; Klein G; Jablonsky G; Kostuk WJ
Am Heart J; 1990 May; 119(5):1034-41. PubMed ID: 2330861
[TBL] [Abstract][Full Text] [Related]
29. Procainamide and retrograde atrioventricular nodal conduction in man.
Shenasa M; Gilbert CJ; Schmidt DH; Akhtar M
Circulation; 1982 Feb; 65(2):355-62. PubMed ID: 7053895
[TBL] [Abstract][Full Text] [Related]
30. Abrupt loss of constant fusion during entrainment of ventricular tachycardia at a critical paced cycle length.
Yamaura M; Aizawa Y; Chinushi M; Washizuka T; Uchiyama H; Kitazawa H
Jpn Heart J; 2001 Jan; 42(1):67-78. PubMed ID: 11324808
[TBL] [Abstract][Full Text] [Related]
31. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
Chiamvimonvat N; Mitchell LB; Gillis AM; Wyse DG; Sheldon RS; Duff HJ
Am J Cardiol; 1992 Sep; 70(6):598-604. PubMed ID: 1324598
[TBL] [Abstract][Full Text] [Related]
32. Identification of patients with sustained ventricular tachycardia by frequency analysis of signal-averaged electrocardiograms despite the presence of bundle branch block.
Lindsay BD; Markham J; Schechtman KB; Ambos HD; Cain ME
Circulation; 1988 Jan; 77(1):122-30. PubMed ID: 3335063
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics of procainamide in patients with ventricular tachyarrhythmias.
Liem LB; Yee YG; Swerdlow CD; Kates RE
J Clin Pharmacol; 1988 Nov; 28(11):984-9. PubMed ID: 3243920
[TBL] [Abstract][Full Text] [Related]
34. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
35. Entrainment of ventricular tachycardia by atrial depolarizations.
Almendral JM; Gottlieb C; Marchlinski FE; Buxton AE; Doherty JU; Josephson ME
Am J Cardiol; 1985 Aug; 56(4):298-304. PubMed ID: 4025169
[TBL] [Abstract][Full Text] [Related]
36. Resetting response patterns during sustained ventricular tachycardia: relationship to the excitable gap.
Almendral JM; Stamato NJ; Rosenthal ME; Marchlinski FE; Miller JM; Josephson ME
Circulation; 1986 Oct; 74(4):722-30. PubMed ID: 3757186
[TBL] [Abstract][Full Text] [Related]
37. The effects of QRS duration and pacing sites on the acute hemodynamic changes during right ventricular pacing.
Hong YJ; Yang BR; Sim DS; Lim SY; Lee SH; Lim JH; Kim HG; Park OY; Kim JH; Kim W; Kim NH; Ahn YK; Jeong MH; Cho JG; Park JC; Kang JC
Korean J Intern Med; 2005 Mar; 20(1):15-20. PubMed ID: 15906948
[TBL] [Abstract][Full Text] [Related]
38. The clinical electrophysiology of intravenous indecainide.
Horowitz LN; Spielman SR; Webb CR; Morganroth J; Greenspan AM
Am Heart J; 1985 Oct; 110(4):784-8. PubMed ID: 4050649
[TBL] [Abstract][Full Text] [Related]
39. The human atrial strength-interval relation. Influence of cycle length and procainamide.
Buxton AE; Marchlinski FE; Miller JM; Morrison DF; Frame LH; Josephson ME
Circulation; 1989 Feb; 79(2):271-80. PubMed ID: 2914346
[TBL] [Abstract][Full Text] [Related]
40. The use of the block cycle length as a safe and efficient means of interrupting sustained ventricular tachycardia and its pharmacological modification.
Ohira K; Niwano S; Furushima H; Taneda K; Chinushi M; Aizawa Y
Pacing Clin Electrophysiol; 1998 Sep; 21(9):1686-92. PubMed ID: 9744429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
